211 related articles for article (PubMed ID: 24946937)
1. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
[TBL] [Abstract][Full Text] [Related]
2. Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcoma.
Davis IJ; McFadden AW; Zhang Y; Coxon A; Burgess TL; Wagner AJ; Fisher DE
Cancer Res; 2010 Jan; 70(2):639-45. PubMed ID: 20068147
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
5. Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.
Moritake H; Sugimoto T; Asada Y; Yoshida MA; Maehara Y; Epstein AL; Kuroda H
Cancer Genet Cytogenet; 2002 May; 135(1):48-56. PubMed ID: 12072203
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts.
Hiraga H; Nojima T; Abe S; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
Virchows Arch; 1997 Jul; 431(1):45-51. PubMed ID: 9247632
[TBL] [Abstract][Full Text] [Related]
8. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
9. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
10. EWS/ATF1 expression induces sarcomas from neural crest-derived cells in mice.
Yamada K; Ohno T; Aoki H; Semi K; Watanabe A; Moritake H; Shiozawa S; Kunisada T; Kobayashi Y; Toguchida J; Shimizu K; Hara A; Yamada Y
J Clin Invest; 2013 Feb; 123(2):600-10. PubMed ID: 23281395
[TBL] [Abstract][Full Text] [Related]
11. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines.
Sakumoto M; Oyama R; Takahashi M; Takai Y; Kito F; Shiozawa K; Qiao Z; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):163-176. PubMed ID: 29197033
[TBL] [Abstract][Full Text] [Related]
12. EWS-ATF1 fusion transcripts in gastrointestinal tumors previously diagnosed as malignant melanoma.
Covinsky M; Gong S; Rajaram V; Perry A; Pfeifer J
Hum Pathol; 2005 Jan; 36(1):74-81. PubMed ID: 15712185
[TBL] [Abstract][Full Text] [Related]
13. Cell-type dependent enhancer binding of the EWS/ATF1 fusion gene in clear cell sarcomas.
Komura S; Ito K; Ohta S; Ukai T; Kabata M; Itakura F; Semi K; Matsuda Y; Hashimoto K; Shibata H; Sone M; Jo N; Sekiguchi K; Ohno T; Akiyama H; Shimizu K; Woltjen K; Ozawa M; Toguchida J; Yamamoto T; Yamada Y
Nat Commun; 2019 Sep; 10(1):3999. PubMed ID: 31488818
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).
Wang WL; Mayordomo E; Zhang W; Hernandez VS; Tuvin D; Garcia L; Lev DC; Lazar AJ; López-Terrada D
Mod Pathol; 2009 Sep; 22(9):1201-9. PubMed ID: 19561568
[TBL] [Abstract][Full Text] [Related]
15. Association of the t(12;22)(q13;q12) EWS/ATF1 rearrangement with polyphenotypic round cell sarcoma of bone: a case report.
Somers GR; Viero S; Nathan PC; Teshima I; Pereira C; Zielenska M
Am J Surg Pathol; 2005 Dec; 29(12):1673-9. PubMed ID: 16327442
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
[TBL] [Abstract][Full Text] [Related]
17. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
[TBL] [Abstract][Full Text] [Related]
18. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.
Tazzari M; Palassini E; Vergani B; Villa A; Rini F; Negri T; Colombo C; Crippa F; Morosi C; Casali PG; Pilotti S; Stacchiotti S; Rivoltini L; Castelli C
BMC Cancer; 2015 Feb; 15():58. PubMed ID: 25880253
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.
Liu S; Cheng H; Kwan W; Lubieniecka JM; Nielsen TO
Mol Cancer Ther; 2008 Jun; 7(6):1751-61. PubMed ID: 18566246
[TBL] [Abstract][Full Text] [Related]
20. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
